Financhill
Back

ProPhase Labs Stock Predictions

ProPhase Labs Stock Forecast

  • Over the next 52 weeks, ProPhase Labs has on average historically risen by 67.5% based on the past 29 years of stock performance.
  • ProPhase Labs has risen higher in 15 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.72%
  • Is ProPhase Labs Stock Undervalued?
    The current ProPhase Labs [PRPH] share price is $5.42. The Score for PRPH is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • PRPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will ProPhase Labs Stock Go Up Next Year?

  • Over the next 52 weeks, ProPhase Labs has on average historically risen by 67.5% based on the past 29 years of stock performance.

ProPhase Labs Stock Rating

Buy
54
ProPhase Labs (PRPH) is a Buy

Is ProPhase Labs overpriced?

  • ProPhase Labs has risen higher in 15 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.72%

ProPhase Labs Stock Price History

Is PRPH stock going to rise?

  • The current trend is relatively stagnant and PRPH is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
prophaselabs.com

52-Week Data

52-Week High:
9.94
52-Week Low:
4.05

Prediction Charts

Market Cap:
103.41M
Price in USD:
5.42
Volume:
38.39K
Beta:
0.58

Technical Analysis

SMA50:
5.51
SMA100:
5.20
SMA200:
5.13
52-Wk Change:
-40.64%

Stock Predictions

  • Is ProPhase Labs stock public?
    Yes, ProPhase Labs is a publicly traded company.
  • What is the ProPhase Labs stock quote today?
    The ProPhase Labs stock price is 5.42 USD today.
  • How to buy ProPhase Labs stock online?
    You can buy ProPhase Labs shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-16 6.54 7.36 7.48 6.27
Apr-17 7.47 6.22 7.47 6.05
Apr-18 6.32 5.44 6.32 5.33
Apr-19 5.31 5.19 5.31 5.05
Apr-22 5.17 4.90 5.17 4.90
Apr-23 4.89 5.20 5.39 4.89
Apr-24 5.17 5.06 5.46 5.05
Apr-25 5.06 4.95 5.23 4.90
Apr-26 4.95 4.71 4.95 4.60
Apr-29 4.77 4.61 4.84 4.60
Apr-30 4.59 4.58 4.73 4.45
May-1 4.58 5.16 5.32 4.58
May-2 5.25 5.31 5.35 5.01
May-3 5.30 5.42 5.50 5.20

ProPhase Labs Earnings

ProPhase Labs Earnings Report: Per Share ProPhase Labs Earnings Q1 Q2 Q3 and Q4 last year and next year.

ProPhase Labs Forecast Revenue Growth

ProPhase Labs Stock Analysis: Historical quarterly revenues per share for ProPhase Labs and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.09 per share, and an increase next year of $1.31 per share.

* ProPhase Labs stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.